Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors
Wenwen Wang(Second Affiliated Hospital of Zhejiang University), Lei Chen(Cincinnati Children's Hospital Medical Center), Dong Gao(Chinese Academy of Sciences), Xinyao Qiu(Second Military Medical University), Yan Zhao(Fudan University), Jinxia Bao(Second Military Medical University), Tinggan Yuan(ShanghaiTech University), Siyun Shen(Second Military Medical University), Peng Wang(Henan Provincial People's Hospital), Yani Zhang(Yangzhou University), Xing Zheng(Xi'an University of Technology), Hongyang Wang(Second Military Medical University), Lili Ma(ShanghaiTech University), Yanjing Zhu(Second Military Medical University), Yali Zong(Fudan University), Xiaofang Zhao(Fudan University Shanghai Cancer Center), Shuai Yang(Sichuan Agricultural University)
Cited by 5
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
|Nature Communications|2018|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing
|Cell Discovery|2020|786